Bay Street News, November 13th, 2024

Company achieves positive Adjusted EBITDA* for the third consecutive quarter, reaching $0.9 million year-to-date, a $4.3 million improvement year-on-year Third-quarter […]

– Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology – […]

Preliminary third quarter 2024 revenue to be approximately $113 million* Q3 materials grew 10% year-over-year and 9% sequentially, offset by […]

MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its […]

MELBOURNE, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) announces that […]

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human […]

LOS ANGELES, Nov. 13, 2024 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leading electric truck […]

VIRGINIA CITY, Nev., Nov. 13, 2024 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced the […]

Company Announces Consecutive Surge in Quarterly Revenues; Provides Positive Outlook for Fiscal Year 2025; Ongoing Expansion and New Product Lines […]

Third Quarter 2024Robust TPV growth, up 41% YoY and 8% QoQ, driven by strong performance across various verticals and countriesRecord […]